Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Psychol Med. 2011 Feb 2;41(9):1889–1896. doi: 10.1017/S0033291711000079

Table 3.

a. Association between baseline diabetes status (using fasting glucose) and risk of future depressive symptoms (n= 2930)*

Cases/N Model 1
OR (95% CI)
Model 2
OR (95% CI)
Model 3
OR (95% CI)
Non-diabetic 220/2244 1.00 1.00 1.00
IFG 35/385 0.86 (0.57 – 1.30) 0.94 (0.62 – 1.43) 0.92 (0.60 – 1.39)
Diabetic 50/301 1.57 (1.07 – 2.29) 1.55 (1.05 – 2.30) 1.52 (1.01 – 2.30)
p-trend 0.038 0.071 0.08

b. Association between baseline diabetes status (using glycated haemoglobin) and risk of future depressive symptoms (n= 4338)
Non-diabetic 397/3712 1.00 1.00 1.00
IGT 46/280 1.53 (1.05 – 2.24) 1.39 (0.94 – 2.04) 1.37 (0.93 – 2.02)
Diabetic 55/346 1.46 (1.02 – 2.07) 1.35 (0.94 – 1.92) 1.36 (0.94 – 1.97)
p-trend 0.016 0.087 0.105

Model 1 adjusted for age and baseline CES-D score.

Model 2 adjusted as model 1 plus for sex, smoking, alcohol intake, physical activity, social status

Model 3 adjusted as model 2 plus for C-reactive protein, cholesterol, body mass index.

Diabetes categories based on fasting glucose and self report; non-diabetic (fasting glucose <5.6 mmol/l and no self-reported diabetes), impaired fasting glucose [IFG] (fasting glucose= 5.6-6.9 mmol/l), diabetic (based on either fasting glucose ≥7.0 mmol/l, self reported doctors diagnosis or use of diabetes medication).

*

data unavailable in1408 participants.

Diabetes categories based on A1C values and self report; non-diabetic (A1C <6 % and no self-reported diabetes), impaired glucose tolerance [IGT] (A1C= 6.0 – 6.5 % and no self-reported diabetes), diabetic (based on either A1C >6.5%, self reported doctors diagnosis or use of diabetes medication).